FDA expects that all data be reliable and accurate (see the “Background” section). CGMP regulations and guidance allow for flexible and risk-based strategies to prevent and detect data integrity issues. Firms should implement  meaningful and effective strategies to manage their data integrity risks based on their process understanding and knowledge management of technologies and business models.

Data Integrity and Compliance With Drug CGMP .Questions and Answers Guidance for Industry